116 related articles for article (PubMed ID: 15539136)
1. Ontology-based knowledge management of troglitazone-induced hepatotoxicity.
Hug H; Dannecker R; Schindler R; Bagatto D; Stephan A; Wess RA; Gut J
Drug Discov Today; 2004 Nov; 9(22):948-54. PubMed ID: 15539136
[No Abstract] [Full Text] [Related]
2. Troglitazone.
Yokoi T
Handb Exp Pharmacol; 2010; (196):419-35. PubMed ID: 20020270
[TBL] [Abstract][Full Text] [Related]
3. Rules and laws of drug hepatotoxicity.
Kaplowitz N
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):231-3. PubMed ID: 16552791
[No Abstract] [Full Text] [Related]
4. Troglitazone-associated hepatotoxicity treated successfully with steroids.
Prendergast KA; Berg CL; Wisniewski R
Ann Intern Med; 2000 Nov; 133(9):751. PubMed ID: 11074925
[No Abstract] [Full Text] [Related]
5. Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.
Masubuchi Y
Drug Metab Pharmacokinet; 2006 Oct; 21(5):347-56. PubMed ID: 17072088
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced liver injury].
Ikeda T
Nihon Yakurigaku Zasshi; 2006 Jun; 127(6):454-9. PubMed ID: 16880695
[No Abstract] [Full Text] [Related]
7. Drug-induced idiosyncratic hepatotoxicity: prevention strategy developed after the troglitazone case.
Ikeda T
Drug Metab Pharmacokinet; 2011; 26(1):60-70. PubMed ID: 21178300
[TBL] [Abstract][Full Text] [Related]
8. Hy's law: predicting serious hepatotoxicity.
Temple R
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):241-3. PubMed ID: 16552790
[No Abstract] [Full Text] [Related]
9. How can 'Hy's law' help the clinician?
Senior JR
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):235-9. PubMed ID: 16552792
[No Abstract] [Full Text] [Related]
10. Troglitazone and liver injury: in search of answers.
Chojkier M
Hepatology; 2005 Feb; 41(2):237-46. PubMed ID: 15657914
[No Abstract] [Full Text] [Related]
11. Substituting for troglitazone (Rezulin).
Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
[No Abstract] [Full Text] [Related]
12. 'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.
Lewis JH
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):221-9. PubMed ID: 16444771
[No Abstract] [Full Text] [Related]
13. Did this drug cause my patient's hepatitis?
Kaplowitz N; Lewis JH; Watkins PB
Ann Intern Med; 2003 Jan; 138(2):159-60; author reply 159-60. PubMed ID: 12529106
[No Abstract] [Full Text] [Related]
14. Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction.
Maniratanachote R; Shibata A; Kaneko S; Yamamori I; Wakasugi T; Sawazaki T; Katoh K; Tokudome S; Nakajima M; Yokoi T
Toxicology; 2005 Dec; 216(1):15-23. PubMed ID: 16115720
[TBL] [Abstract][Full Text] [Related]
15. Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.
Nozawa T; Sugiura S; Nakajima M; Goto A; Yokoi T; Nezu J; Tsuji A; Tamai I
Drug Metab Dispos; 2004 Mar; 32(3):291-4. PubMed ID: 14977862
[TBL] [Abstract][Full Text] [Related]
16. Lessons from the glitazones: a story of drug development.
Gale EA
Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
18. Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.
Graham DJ; Drinkard CR; Shatin D
Am J Gastroenterol; 2003 Jan; 98(1):175-9. PubMed ID: 12526954
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of troglitazone hepatotoxicity.
Smith MT
Chem Res Toxicol; 2003 Jun; 16(6):679-87. PubMed ID: 12807350
[No Abstract] [Full Text] [Related]
20. Troglitazone (Rezulin) and hepatic injury.
Faich GA; Moseley RH
Pharmacoepidemiol Drug Saf; 2001; 10(6):537-47. PubMed ID: 11828837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
